Otsuka Holdings
4578.T
#620
Rank
โ‚น2.831 T
Marketcap
โ‚น5,240
Share price
0.27%
Change (1 day)
75.31%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2023 (TTM): โ‚น200.15

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น204.70. In 2022 the company made an earnings per share (EPS) of โ‚น154.35 a decrease over its 2021 EPS that were of โ‚น176.15.

EPS history for Otsuka Holdings from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น200.1529.68%
2022โ‚น154.35-12.38%
2021โ‚น176.15-18.58%
2020โ‚น216.3518.81%
2019โ‚น182.1055.85%
2018โ‚น116.84-25.05%
2017โ‚น155.8910.15%
2016โ‚น141.537.74%
2015โ‚น131.36-39.2%
2014โ‚น216.04-20.14%
2013โ‚น270.5351.58%
2012โ‚น178.48-6.65%
2011โ‚น191.1929.28%
2010โ‚น147.89